North America Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report covers North America Genetic Diagnostic Testing Companies and it is Segmented by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, and Other Types), Disease (Alzheimer's Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, and Rare Diseases), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Country (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

North America Genetic Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Genetic Testing Industry Overview

The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. These include 23&Me Inc., Abbott Laboratories, Ariosa Diagnostics Inc., Danaher Corporation (Cepheid Inc.), Illumina Inc., DiaSorin Spa (Luminex Corporation), Biorad Laboratories Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, and F Hoffmann-La Roche Ltd.

North America Genetic Testing Market Leaders

  1. Abbott Laboratories

  2. Illumina Inc.

  3. 23&Me Inc.

  4. F Hoffmann-La Roche Ltd

  5. Danaher Corporation (Cepheid Inc.)

  6. *Disclaimer: Major Players sorted in no particular order
North America Genetic Testing Market Concentration

North America Genetic Testing Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?